Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous skin-derived adult keratinocytes and fibroblasts cell-sheet (fibrin-hyaluronic acid matrix)
- Development stage
- Unknown
- Lead developer
- Red Andaluza de Terapias Avanzadas
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
This autologous tissue-engineered skin substitute is an advanced therapy medicinal product (ATMP) developed by the Andalusian Network for Design and Translation of Advanced Therapies. It consists of a bilayered structure where autologous fibroblasts are embedded in a scaffold composed of human fibrin and hyaluronic acid, acting as a dermal equivalent, while autologous keratinocytes are cultured on the surface to form an epidermal layer. The product is specifically designed for the reconstruction of skin defects, particularly those resulting from Mohs micrographic surgery for the treatment of basal cell carcinoma. By providing a functional cellular environment and a biocompatible matrix, it promotes wound healing, reduces scarring, and facilitates the regeneration of the skin's natural architecture without the risk of immune rejection associated with allogeneic grafts.
- Other names
- autologous human tissue-engineered skin (keratinocytes and fibroblasts) on a fibrin-hyaluronic acid matrixfibrin-hyaluronic acid skin substituteautologous skin-derived adult keratinocytes and fibroblasts cell-sheet
Beyond the preview
Go deeper on autologous skin-derived adult keratinocytes and fibroblasts cell-sheet (fibrin-hyaluronic acid matrix).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous skin-derived adult keratinocytes and fibroblasts cell-sheet (fibrin-hyaluronic acid matrix).